VCL-CB01, an injectable bivalent plasmid DNA vaccine for potential protection against CMV disease and infection.
about
Prevention of maternal cytomegalovirus infection: current status and future prospects.The "silent" global burden of congenital cytomegalovirus.Update on the current status of cytomegalovirus vaccines.Prophylactic and therapeutic adenoviral vector-based multivirus-specific T-cell immunotherapy for transplant patients.DNA vaccine prime followed by boost with live attenuated virus significantly improves antigen-specific T cell responses against human cytomegalovirus.Desirability and feasibility of a vaccine against cytomegalovirus.Protection from cytomegalovirus viremia following glycoprotein B vaccination is not dependent on neutralizing antibodies.
P2860
Q34272089-9F63444E-A55F-405C-B23A-87518084A717Q36558293-FA83AFB4-BDDA-45C2-AD69-3B70F683CC03Q36678423-A94AACC7-401D-480F-802D-4B02F0DD6D8EQ37203522-9C93E103-C63A-4657-89BC-A5E58D52340EQ37530479-0EEBFB35-C1A2-4EED-B7B0-595A9F60CAE8Q38100041-7B176ACA-7AEE-4E2B-9D4F-E2E699732FD9Q52568669-DBDB8C17-1BA9-48CE-84C2-ED473F505A92
P2860
VCL-CB01, an injectable bivalent plasmid DNA vaccine for potential protection against CMV disease and infection.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
VCL-CB01, an injectable bivale ...... nst CMV disease and infection.
@ast
VCL-CB01, an injectable bivale ...... nst CMV disease and infection.
@en
type
label
VCL-CB01, an injectable bivale ...... nst CMV disease and infection.
@ast
VCL-CB01, an injectable bivale ...... nst CMV disease and infection.
@en
prefLabel
VCL-CB01, an injectable bivale ...... nst CMV disease and infection.
@ast
VCL-CB01, an injectable bivale ...... nst CMV disease and infection.
@en
P2860
P1476
VCL-CB01, an injectable bivale ...... nst CMV disease and infection.
@en
P2093
Mark R Schleiss
P2860
P304
P577
2009-10-01T00:00:00Z